Mesenchymal stem cells for cartilage repair in osteoarthritis
Open Access
- 9 July 2012
- journal article
- review article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 3 (4), 25
- https://doi.org/10.1186/scrt116
Abstract
Osteoarthritis (OA) is a degenerative disease of the connective tissue and progresses with age in the older population or develops in young athletes following sports-related injury. The articular cartilage is especially vulnerable to damage and has poor potential for regeneration because of the absence of vasculature within the tissue. Normal load-bearing capacity and biomechanical properties of thinning cartilage are severely compromised during the course of disease progression. Although surgical and pharmaceutical interventions are currently available for treating OA, restoration of normal cartilage function has been difficult to achieve. Since the tissue is composed primarily of chondrocytes distributed in a specialized extracellular matrix bed, bone marrow stromal cells (BMSCs), also known as bone marrow-derived 'mesenchymal stem cells' or 'mesenchymal stromal cells', with inherent chondrogenic differentiation potential appear to be ideally suited for therapeutic use in cartilage regeneration. BMSCs can be easily isolated and massively expanded in culture in an undifferentiated state for therapeutic use. Owing to their potential to modulate local microenvironment via anti-inflammatory and immunosuppressive functions, BMSCs have an additional advantage for allogeneic application. Moreover, by secreting various bioactive soluble factors, BMSCs can protect the cartilage from further tissue destruction and facilitate regeneration of the remaining progenitor cells in situ. This review broadly describes the advances made during the last several years in BMSCs and their therapeutic potential for repairing cartilage damage in OA.Keywords
This publication has 45 references indexed in Scilit:
- Chondrogenesis and cartilage tissue engineering: the longer road to technology developmentTrends in Biotechnology, 2011
- Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case seriesJournal of Medical Case Reports, 2011
- Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSCCell Communication and Signaling, 2011
- Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patientsInternational Journal of Rheumatic Diseases, 2011
- Stem Cells and Cartilage Development: Complexities of a Simple TissueThe International Journal of Cell Cloning, 2010
- The Clinical Use of Human Culture–Expanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage DefectsCARTILAGE, 2010
- Characterization of proteoglycan production and processing by chondrocytes and BMSCs in tissue engineered constructsOsteoarthritis and Cartilage, 2008
- Mesenchymal stem cells in arthritic diseasesArthritis Research & Therapy, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stromaCell and tissue research, 2005